Extensive pelvic endometriosis with malignant change in tamoxifen-treated postmenopausal women

International Journal of Gynecological Cancer

Volumn 13, Issue 3, 2003, Pages 376-380

  Bese, Tugan ^a,c   Simsek, Y ^a   Bese, N ^b   Ilvan, S ^b   Arvas, M ^a  

^a ISTANBUL UNIVERSITY   (Turkey)

^b ISTANBUL UNIVERSITY   (Turkey)

^c NONE   (Turkey)

Author keywords

Cervical carcinoma; Endometriosis; Postmenopause; Tamoxifen

Indexed keywords

TAMOXIFEN; ANTINEOPLASTIC HORMONE AGONISTS AND ANTAGONISTS;

AGED; ARTICLE; BREAST CARCINOMA; CASE REPORT; CLINICAL FEATURE; ENDOMETRIOSIS; ENDOMETRIUM HYPERPLASIA; FEMALE; HUMAN; HUMAN TISSUE; HYPERPLASTIC POLYP; HYSTERECTOMY; HYSTEROSCOPE; MALIGNANT TRANSFORMATION; PELVIS; PELVIS TUMOR; POLYP; PRIORITY JOURNAL; RECTUM; SALPINGOOOPHORECTOMY; UTERINE CERVIX; UTERINE CERVIX CANCER; UTERUS BLEEDING; ADENOCARCINOMA; ADNEXA DISEASE; BREAST TUMOR; CELL TRANSFORMATION; CHEMICALLY INDUCED DISORDER; GYNECOLOGIC SURGERY; METHODOLOGY; PATHOLOGY; POSTMENOPAUSE; UTERINE CERVIX TUMOR;

ADENOCARCINOMA; ADNEXAL DISEASES; AGED; ANTINEOPLASTIC AGENTS, HORMONAL; BREAST NEOPLASMS; CELL TRANSFORMATION, NEOPLASTIC; ENDOMETRIOSIS; FEMALE; GYNECOLOGIC SURGICAL PROCEDURES; HUMANS; PELVIS; POSTMENOPAUSE; TAMOXIFEN; UTERINE CERVICAL NEOPLASMS;

EID: 0642315314     PISSN: 1048891X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1525-1438.2003.13188.x     Document Type: Article

References (11)

1. Nishimura N, Hachisuga T, Saita T, Kawarabayashi T. Subsequent endometrial carcinoma with adjuvant tamoxifen treatment in Japanese breast cancer patients. Int J Gynecol Cancer 2001;11:272-6.
2. Bese T, Kösebay D, Demirkiran F et al. Ultrasonografic appearance of endometrium in postmenopausal breast cancer patients receiving tamoxifen. Eur J Obstet Gynecol Repiod Biol 1996;67:157-62.
3. Cohen I, Altaras MM, Lew S et al. Ovarian endometrioid carcinoma and endometriosis developing in a postmenopausal breast cancer patient during tamoxifen therapy: a case report and review of the literature. Gynecol Oncol 1994;55:443-7.
4. Ismail SM, Maulik TG. Tamoxifen-associated postmenopausal endometriosis. Hisopathology 1997;30:187-91.
5. Mourits MJE, De Vries EGG, Willemse PHB, Ten Hoor KA, Hollema H, Van der Zee AGJ. Tamoxifen treatment and gynecologic side effects: a review. Obstet Gynecol 2001;97:855-66.
6. Kadaba R, Simpson CW. Disparate effect of tamoxifen in rats with experimentally induced endometriosis. Endocrinology 1990;126:3263-7.
7. Rose PG, Alvarez B, MacLennan GT. Exacerbation of endometriosis as a result of premenopausal tamoxifen exposure. Am J Obstet Gynecol 2000;183:507-8.
8. Morgan MA, Gincherman Y, Mikuta JJ. Endometriosis and tamoxifen therapy. Int J Gynaecol Obstet 1994;45:55-7.
9. Swiersz LM. Role of endometriosis in cancer and tumor development. Ann N Y Acad Sci 2002;955:281-92.
10. McCluggage WG, Desai V, Manek S. Tamoxifen-associated postmenopausal adenomyosis exhibits stromal fibrosis, glandular dilatation and epithelial metaplasias. Histopathology 2000;37:340-6.
11. Hajjar LR, Kim WS, Nolan GH, Turner S, Raju UR. Intestinal and pelvic endometriosis presenting as a tumor and associated with tamoxifen therapy. Obstet Gynecol 1993;82:6424.